Pharmaceutical giant Merck has announced plans to invest €440 million in its Co Cork operations, and it will create more than 370 permanent jobs by the end of 2027.
The €440m investment will include the expansion of Merck’s facility in Carrigtwohill and a new manufacturing facility at Blarney Business Park in Cork.
Merck said this is the single largest investment the multinational company has made in the life sciences sector.
Merck’s Managing Director and Head of Cork Operations, Martin McAuliffe, said the investment was “a statement of Merck’s commitment to our Irish operations”.
“These new investments secure Merck’s bright future in Cork and enable us to expand our capabilities here, creating new job opportunities in the technology of the future.”
Speaking at the site’s official announcement, Taoiseach Micheál Martin said: “This investment speaks volumes about our capacity to provide the right conditions for multinational organisations to grow their operations. Ireland’s development of a strong life sciences ecosystem has been one of our greatest economic successes. I am delighted that Merck has chosen Cork for its latest investment. I wish the team continued success, as they work towards improving lives around the world.”
Martin Shanahan, CEO of IDA Ireland, said the investment “will have a significant positive economic impact on the South-West region”.
“Merck’s decision to expand its footprint is solid evidence of the company’s belief in Ireland’s ability to provide access to world-class talent. I would like to assure the Merck of IDA Ireland team’s continued support and their commitment to this great investment.” I wish you every success.